Pneumocystis jirovecii pneumonia in patients with acute myeloid leukaemia.
Hung ChangMing-Chung KuoTung-Liang LinJin-Hou WuPo-Nan WangPublished in: Internal medicine journal (2018)
The association of Pneumocystis jirovecii pneumonia (PJP) and acute myeloid leukaemia (AML) is not clearly defined. In our experience of 291 patients with AML, 20 (14 males and 6 females, median age 56) developed PJP (incidence 6.8%). Thirteen patients (65%) survived until discharge from hospital. We conclude that PJP is not uncommon among patients with AML. In clinical care of AML, awareness of PJP should be heightened and prophylaxis should be considered.
Keyphrases
- acute myeloid leukemia
- allogeneic hematopoietic stem cell transplantation
- end stage renal disease
- healthcare
- respiratory failure
- ejection fraction
- newly diagnosed
- bone marrow
- chronic kidney disease
- dendritic cells
- liver failure
- risk factors
- prognostic factors
- peritoneal dialysis
- drug induced
- immune response
- acute lymphoblastic leukemia
- hepatitis b virus
- health insurance
- pain management
- patient reported
- acute care